<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id><journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id><journal-title-group><journal-title>Frontiers in Pharmacology</journal-title></journal-title-group><issn pub-type="epub">1663-9812</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7873646</article-id><article-id pub-id-type="publisher-id">580069</article-id><article-id pub-id-type="doi">10.3389/fphar.2020.580069</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Neuroprotective Studies on <italic>Polygonum hydropiper</italic> L. Essential Oils Using Transgenic Animal Models</article-title><alt-title alt-title-type="left-running-head">Tong et al.</alt-title><alt-title alt-title-type="right-running-head">Neuroprotective Potentials of <italic>Polygonum hydropiper</italic> Oils</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tong</surname><given-names>Xin</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1037049/overview"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xiaoling</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="author-notes" rid="fn2">
<sup>&#x02020;&#x02020;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ayaz</surname><given-names>Muhammad</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="corresp" rid="c001">*</xref><xref ref-type="author-notes" rid="fn1">
<sup>&#x02020;</sup>
</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/294513/overview"/></contrib><contrib contrib-type="author"><name><surname>Ullah</surname><given-names>Farhat</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/58258/overview"/></contrib><contrib contrib-type="author"><name><surname>Sadiq</surname><given-names>Abdul</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/304789/overview"/></contrib><contrib contrib-type="author"><name><surname>Ovais</surname><given-names>Muhammad</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shahid</surname><given-names>Muhammad</given-names></name><xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/435425/overview"/></contrib><contrib contrib-type="author"><name><surname>Khayrullin</surname><given-names>Mars</given-names></name><xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hazrat</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label><sup>1</sup></label>Department of Clinical Medicine, Heilongjiang University of Chinese Medicine, <addr-line>Harbin</addr-line>, <country>China</country>
</aff><aff id="aff2">
<label><sup>2</sup></label>Department of Imaging, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, <addr-line>Harbin</addr-line>, <country>China</country>
</aff><aff id="aff3">
<label><sup>3</sup></label>Department of Pharmacy, University of Malakand, <addr-line>Chakdara</addr-line>, <country>Pakistan</country>
</aff><aff id="aff4">
<label><sup>4</sup></label>CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, <addr-line>Beijing</addr-line>, <country>China</country>
</aff><aff id="aff5">
<label><sup>5</sup></label>University of Chinese Academy of Sciences, <addr-line>Beijing</addr-line>, <country>China</country>
</aff><aff id="aff6">
<label><sup>6</sup></label>Department of Pharmacy, Sarhad University of Information Technology, <addr-line>Peshawar</addr-line>, <country>Pakistan</country>
</aff><aff id="aff7">
<label><sup>7</sup></label>K.G. Razumovsky Moscow State University of Technologies and Management (the First Cossack University), <addr-line>Moscow</addr-line>, <country>Russia</country>
</aff><aff id="aff8">
<label><sup>8</sup></label>Department of Botany, University of Malakand, <addr-line>Chakdara</addr-line>, <country>Pakistan</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/254866">Micha&#x00142; Tomczyk</ext-link>, Medical University of Bialystok, Poland</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/874043">Kooi Yeong Khaw</ext-link>, Monash University Malaysia, Malaysia</p><p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/417250">Inamullah Hakeem Said</ext-link>, Jacobs University Bremen, Germany</p></fn><corresp id="c001">*Correspondence: Muhammad Ayaz, <email>Ayazuop@gmail.com</email></corresp><fn id="fn1"><label><sup>&#x02020;</sup></label><p>
<bold>ORCID:</bold> Muhammad Ayaz, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-4299-2445">orcid.org/0000-0002-4299-2445</ext-link>
</p></fn><fn id="fn2"><label><sup>&#x02020;&#x02020;</sup></label><p>This author share co-first authorship</p></fn><fn fn-type="other"><p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p></fn></author-notes><pub-date pub-type="epub"><day>27</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>580069</elocation-id><history><date date-type="received"><day>04</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>08</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2021 Tong, Li, Ayaz, Ullah, Sadiq, Ovais, Shahid, Khayrullin and Hazrat.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Tong, Li, Ayaz, Ullah, Sadiq, Ovais, Shahid, Khayrullin and Hazrat</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="580069.pdf"/><abstract><p>
<italic>Polygonum hydropiper</italic> L. and related species are reported to possess neuroprotective potentials. In an attempt to validate its anti-Alzheimer&#x02019;s potentials, leaf oils (Ph. Lo) were extensively evaluated in this study against several <italic>in vitro</italic> and <italic>in vivo</italic> models of Alzheimer&#x02019;s disease. The Ph. Lo were tested against pathological targets of Alzheimer&#x02019;s diseases (ADs). The <italic>in vitro</italic> and <italic>in vivo</italic> assays were done for cholinesterase inhibition, anti-radical properties and cognitive assessments using transgenic animal models. In preliminary cholinesterase inhibition assays, Ph. Lo were more active against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), 1,1-diphenyl-2-picrylhydrazyl (DPPH), 2,2-azinobis (3-ethylbenzthiazoline)-6-sulfonic acid (ABTS), and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) radicals. Subsequently, Ph. Lo was evaluated for its effects on special memory, exploratory behavior, and coordination using shallow water maze (SWM), Y-maze, open filed, and balance beam tests. Animal pre-genotyping was done <italic>via</italic> polymerase chain reaction (PCR) to confirm amyloid precursor protein (APP) transgene, and after completion of drug therapy, brain homogenates from the cortex and hippocampus were evaluated for cholinesterase and free radical studies. In SWM task, disease control animals treated with 10&#x000a0;mg/kg of Ph. Lo for 5&#x000a0;days exhibited significant improvement in cognitive performance indicated by low escape times on 5th day compared with normal animals. In the Y-maze test, transgenic animals showed higher spontaneous alternation behavior than disease control animals and standard control group animals. Ph. Lo therapy has improved the exploratory behavior and declined anxiety behavior in diseased animals as accessed <italic>via</italic> open field test. Ph. Lo administration significantly augmented the motor and coordination abilities of transgenic animals when compared to other groups of animals and declined AChE, BChE activities as well as free radicals load in the cortex and hippocampus tissues. Based on our finding, it is concluded that Ph. Lo exhibit significant neuroprotective potentials preliminary due to their anti-radicals and cholinesterase inhibitory activities. Ph. Lo need further detailed studies as potential aromatherapy against neurodegenerative disorders.</p></abstract><kwd-group><kwd><italic>P. hydropiper</italic></kwd><kwd>Alzheimer&#x02019;s disease</kwd><kwd>cholinesterase&#x02019;s</kwd><kwd>antioxidants</kwd><kwd>a&#x003b2;</kwd><kwd>essential oil</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Alzheimer&#x02019;s disease (AD), a neurodegenerative disorder of the old age, is associated with cognitive disabilities, behavioral turbulence, and imperfection in routine activities. AD is a major cause of dementia, accounting for 60&#x02013;80 percent of the cases (<xref rid="B3" ref-type="bibr">Ali et al., 2017</xref>; <xref rid="B51" ref-type="bibr">Mir et al., 2019</xref>). According to AD association, about 33.9 million people of the world have been affected by AD, and its prevalence is expected to increase three folds by the next 40&#x000a0;years (<xref rid="B4" ref-type="bibr">Alzheimer&#x02019;s, 2010</xref>). The pathological features of AD include the deficiency of essential neurotransmitter acetylcholine (ACh) involved in impulse transmission across the synapse, accumulation of amyloid plaques (A&#x003b2;), neurofibrillary tangles (NFTs), free radical-induced neurodegeneration, and glutametergic abnormalities (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>; <xref rid="B56" ref-type="bibr">Ovais et al., 2018</xref>). Among the behavioral tools used to assess cognitive performance, special memory, exploratory behavior, coordination and response to neuroprotective agents, shallow water maze (SWM), Y-maze, open field, and balance beam are frequently applied (<xref rid="B27" ref-type="bibr">Eisdorfer, 2013</xref>). SWM, which is a modified version of Morris water maze (MWM), is specifically designed for mice as they feel difficulty in swimming during MWM tests. This is paddling maze utilizing shallow water which stimulates animals for escape. After drug therapy, escape latency is recorded for experimental animals. SWM is an effective tool for the assessment of special memory in rodents preferably mice (<xref rid="B26" ref-type="bibr">Deacon, 2013</xref>). Y-maze is another behavioral tool widely used to assess special memory in the form of spontaneous alternation behavior (<xref rid="B57" ref-type="bibr">Pocivavsek et al., 2016</xref>). Open field and balance beam tests are used to measure exploratory behavior and motor coordination in animals, respectively (<xref rid="B33" ref-type="bibr">Gould et al., 2009</xref>; <xref rid="B47" ref-type="bibr">Luong et al., 2011</xref>).</p><p>Currently, five drugs (galantamine, tacrine, rivastigmine, donepezil, and memantine) are clinically approved for the management of AD (<xref rid="B9" ref-type="bibr">Ayaz et al., 2015</xref>; <xref rid="B60" ref-type="bibr">Sadiq et al., 2015</xref>; <xref rid="B37" ref-type="bibr">Imran et al., 2017</xref>). These drugs have limited efficacy and are associated with anti-cholinergic side effects. Consequently, there is an imperative need to search out potential anti-Alzheimer&#x02019;s agents with better efficacy and safety profiles. At present, there has been growing interest to investigate natural products that could play a vital role in novel drug discovery owing to the diverse nature of biocompatible secondary metabolites in plants (<xref rid="B58" ref-type="bibr">Rates, 2001</xref>). Various researchers have isolated numerous compounds from medicinal plants that possess significant neuroprotective and anti-Alzheimer&#x02019;s capacities (<xref rid="B35" ref-type="bibr">Hiremathad, 2017</xref>; <xref rid="B11" ref-type="bibr">Ayaz et al., 2017b</xref>; <xref rid="B61" ref-type="bibr">Sadiq et al., 2018</xref>). Among the available drugs, galantamine is derived from plant sources, whereas rivastigmine is a synthetic derivative of naturally occurring compound physostigmine (<xref rid="B66" ref-type="bibr">Ullah et al., 2016</xref>). Compared to the randomly synthesized compounds, the success rate in developing drugs from medicinal plants is considerably high and this fact signifies the search of novel drugs from medicinal plants (<xref rid="B42" ref-type="bibr">Koehn and Carter, 2005</xref>). Several compounds from medicinal plants are reported to exhibit efficacy on multiple targets of AD. For instance, curcumin modulates inflammatory pathways in the CNS, prevents A&#x003b2; aggregation, and scavenges free radicals (<xref rid="B31" ref-type="bibr">Frautschy et al., 2001</xref>; <xref rid="B46" ref-type="bibr">Lim et al., 2001</xref>; <xref rid="B14" ref-type="bibr">Baum and Ng, 2004</xref>; <xref rid="B55" ref-type="bibr">Ono et al., 2004</xref>; <xref rid="B70" ref-type="bibr">Yang et al., 2005</xref>). Consequently, it is in clinical trials as a potential multi-active agent against AD. Several other active phytoconstituents including catechins, myricetin, and gossypetin also inhibit enzymes, A&#x003b2; aggregation, and scavenge free radicals (<xref rid="B59" ref-type="bibr">Rice-Evans et al., 1996</xref>; <xref rid="B12" ref-type="bibr">Ayaz et al., 2019</xref>).</p><p>
<italic>Polygonum hydropiper</italic> L., family Polygonacae, is used in folk medicine for the treatment of various inflammatory diseases caused by free radicals (<xref rid="B8" ref-type="bibr">Ayaz et al., 2014</xref>; <xref rid="B36" ref-type="bibr">Huq et al., 2014</xref>; <xref rid="B50" ref-type="bibr">Mihaylova et al., 2019</xref>; <xref rid="B7" ref-type="bibr">Ayaz et al., 2020</xref>). Additionally, other species of the family have been explored for their potential therapeutic agents against AD and dementia (<xref rid="B19" ref-type="bibr">Chan et al., 2003</xref>; <xref rid="B45" ref-type="bibr">Li et al., 2005</xref>; <xref rid="B20" ref-type="bibr">Chen et al., 2007</xref>). We recently reported the efficacy of &#x003b2;-sitosterol isolated from <italic>P. hydropiper</italic> against oxidative stress, cholinesterase enzymes, and cognitive dysfunctions using the transgenic animal model (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>). In another preliminary study, we investigated the <italic>in vitro</italic> cholinesterase inhibitory and antioxidant potentials of essential oils from leaves and flowers of <italic>P. hydropiper</italic> (<xref rid="B9" ref-type="bibr">Ayaz et al., 2015</xref>). Based on <italic>in vitro</italic> results, the current study was designed to appraise Ph. Lo for its efficacy against cognitive dysfunctions in the transgenic animal model of AD.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2-1"><title>Plant Collection, Processing, and Isolation</title><p>The whole plant of <italic>P. hydropiper</italic> was collected in July 2013, authenticated by Dr Gul Rahim, a botanical taxonomist and in charge of the University of Malakand herbarium. Plant dried sample was placed at the university herbarium, with voucher No. H.UOM.BG.107. Whereas for extraction of leaf oils (Ph. Lo), leaves were collected in September 2014 from Talash Dir. Leaves were properly cleansed with distilled water to remove any adulterants. Ph. Lo were collected <italic>via</italic> Clevenger apparatus and subjected to GC&#x02013;MS analysis for the identification of major constituents as reported previously (<xref rid="B9" ref-type="bibr">Ayaz et al., 2015</xref>).</p></sec><sec id="s2-2"><title>Animals Used and Ethical Approval</title><p>Based on our preliminary <italic>in vitro</italic> results (<xref rid="B9" ref-type="bibr">Ayaz et al., 2015</xref>), Ph. Lo were subjected to detailed <italic>in vivo</italic> studies using double transgenic animals. Transgenic animals expressed with human APP weighing 35&#x02013;40&#x000a0;g were used in the study (<xref rid="B24" ref-type="bibr">Clark, 2011</xref>). This study was evaluated and approved by Departmental Research Ethics Committee (DREC) with reference no. DREC/20160502/01. All animals were maintained under standard conditions and provided food and water <italic>ad libitum</italic>.</p></sec><sec id="s2-3"><title>Genotyping</title><p>Animals were subjected to genotyping <italic>via</italic> PCR for confirmation of transgene before detailed studies following our previously reported protocol (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>) as summarized in <xref rid="T1" ref-type="table">Table 1</xref>, <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Primers sequences for PCR reaction.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="center" rowspan="1" colspan="1">Primer</th><th align="center" rowspan="1" colspan="1">Sequence 5&#x02019;&#x02192;3&#x02019;</th><th align="center" rowspan="1" colspan="1">Primer type</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">IMR3610</td><td align="left" rowspan="1" colspan="1">AGG ACT GAC CAC TCG ACC AG</td><td align="left" rowspan="1" colspan="1">Transgene</td></tr><tr><td align="left" rowspan="1" colspan="1">IMR3611</td><td align="left" rowspan="1" colspan="1">CGG GGG TCT AGT TCT GAC T</td><td align="left" rowspan="1" colspan="1">Transgene</td></tr><tr><td align="left" rowspan="1" colspan="1">IMR7338</td><td align="left" rowspan="1" colspan="1">CTA GGC CAC AGA ATT GAA AGA TCT</td><td align="left" rowspan="1" colspan="1">Internal positive (F)</td></tr><tr><td align="left" rowspan="1" colspan="1">IMR7339</td><td align="left" rowspan="1" colspan="1">GTA GGT GGA AAT TCT AGC ATC ATC C</td><td align="left" rowspan="1" colspan="1">Internal positive (R)</td></tr></tbody></table></table-wrap><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Overview of the genotyping process for the identification of transgenic animals.</p></caption><graphic xlink:href="fphar-11-580069-g001"/></fig></sec><sec id="s2-4"><title>Animal Grouping and Behavioral Studies</title><p>Animals confirmed with transgene were grouped into four, each group containing eight animals (<italic>n</italic> = 8); disease control (untreated transgenic animals provided with normal diet but no drug therapy), standard control (transgenic animals provided with reference drug galantamine), test control (transgenic animals provided with Ph. Lo), and additional normal control group (normal animals on usual diet and no drugs).</p></sec><sec id="s2-5"><title>Administration of Drugs</title><p>The disease control group containing transgenic animals maintained on normal diet, test control group containing transgenic animals administered with Ph. Lo at 10&#x000a0;mg/kg body weight/day (I/P), and reference group transgenic animals received galantamine at the same dose for consecutive 5&#x000a0;days. In the normal control group, normal animals were trained and maintained on the standard diet without any drug administration.</p></sec><sec id="s2-6"><title>Shallow Water Maze (SWM) Task</title><p>Shallow water maze (SWM) was designed (MK2 model/octagonal) following published procedure in the journal of visual experiments (JOVE) (Deacon), and it was already reported in our previous work (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>). Shallow water (20&#x02013;25&#x000b0;C) was maintained in the maze which provides sufficient escape stress to the experimental animals. Maze contains eight true&#x02013;false exits, among which seven are clogged whereas one is open with 40-mm diameter for smooth escape.</p><sec id="s2-6-1"><title>Pre-training</title><p>Experimental animals were divided in different groups, properly marked on the tails for identification, and were subjected to training trials. Each animal received three trails a day, whereby, animals were placed opposite to exit hole and allowed to escape. Subsequent to the end of maximum time (60&#x000a0;s) if animal failed to find the exit, it was manually guided toward the exit way. Each trial was 1&#x000a0;h apart and continued for 9&#x000a0;days.</p></sec></sec><sec id="s2-7"><title>Y-maze Task</title><p>Y-maze is another behavioral tool used for the cognitive assessments of rodents. It consists of three arms, each 30 &#x000d7; 8 &#x000d7; 20&#x000a0;cm having two false and one true exit. Shallow water of about 2&#x000a0;cm depth maintains an escape stress, and visual aids help the animals to develop memory and remember the true exit (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>).</p><sec id="s2-7-1"><title>Pre-training and Test Trials</title><p>All experimental animals were trained for nine consecutive days, with three trials per day (each trial 1&#x000a0;h apart). To start a trial, animals were placed randomly at point opposite to the true exit and allowed to find escape for 60&#x000a0;s. Moreover, percent spontaneous alternation behavior was calculated as<disp-formula id="e1"><mml:math id="M1"><mml:mrow><mml:mtext>%&#x000a0;Alteration&#x000a0;behavior</mml:mtext><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Successive&#x000a0;triplet&#x000a0;sets</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Number&#x000a0;of&#x000a0;Total&#x000a0;enteries</mml:mtext></mml:mrow></mml:mfrac><mml:mo>&#x02212;</mml:mo><mml:mn>2</mml:mn><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
</p><p>At the end of training trials, each animal of the test control group received Ph. Lo at 10&#x000a0;mg/kg body weight (I/P) for 5&#x000a0;days. Whereas the standard control group was administered galantamine, and both parameters were recorded.</p></sec></sec><sec id="s2-8"><title>Open Field</title><p>Open field is an extensively used behavioral tool for the assessment of locomotor behavior of the animals (<xref rid="B5" ref-type="bibr">Arendash et al., 2001</xref>). The experimental tool consists of open box usually of 81 &#x000d7; 81-cm dimensions and 28.5-cm walls. The box floor is usually colored with four lines on each side to make 16 squares of 20 &#x000d7; 20&#x000a0;cm. During test and training trials, animals were introduced into the center of the box and permitted to search for 5&#x000a0;min. Average number of line crossed by animals was noted. Moreover, animals were allowed in the apparatus for 30&#x000a0;min, and time spent in the central and peripheral areas was recorded (<xref rid="B22" ref-type="bibr">Choleris et al., 2001</xref>).</p></sec><sec id="s2-9"><title>Balance Beam</title><p>Subsequent to 9&#x000a0;days training, animals were administered with standard and test drugs (I/P) at the above doses and allowed to cross the wooden beam. Times (sec) were recorded for the animals to successfully cross the beam without slips and discoordination.</p></sec><sec id="s2-10"><title>Neurochemical Studies</title><sec id="s2-10-1"><title>Cholinesterase Inhibitory Studies on Cortical and Hippocampus Brain Tissues</title><p>Owing to the significance of ACh in neurotransmission and cognition, activity of ACh inactivating enzymes (AChE and BChE) was analyzed in the brain tissue homogenates (<xref rid="B68" ref-type="bibr">Whitehouse et al., 1982</xref>). On the last day (5th day) of drug therapy, 1&#x000a0;h of postdrug administration, animals were sacrificed, and cortical and hippocampus tissues were dissected out in ice cold phosphate buffer following our previously reported procedure (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>). Brain tissues were isolated in 0.1&#x000a0;M phosphate buffer saline with 8.0&#x000a0;pH and were homogenized. Thereafter, the homogenates were centrifuged at 1,000 &#x000d7; <italic>g</italic> for about 10&#x000a0;min, and supernatant part was collected. Protein content of the supernatants was estimated <italic>via</italic> the Bradford method (<xref rid="B16" ref-type="bibr">Bradford, 1976</xref>; <xref rid="B38" ref-type="bibr">Isomae et al., 2002</xref>) and was used as an enzyme source following already established Ellman&#x02019;s assay (<xref rid="B28" ref-type="bibr">Ellman et al., 1961</xref>; <xref rid="B64" ref-type="bibr">Trevisan et al., 2003</xref>).</p></sec><sec id="s2-10-2"><title>Assessments of FC and HC Free Radicals Load</title><p>Keeping in view the role of free radicals in neurodegenerative disorders, free radical load was assessed in cortical and hippocampus tissue homogenates post&#x02013;drug therapy following the procedure previously reported (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>). Frontal cortex (FC) and hippocampus (HC) tissue homogenates corresponding to 0.1&#x000a0;mg/ml proteins were homogenized with 1&#x000a0;ml methanol and mixed with 0.4&#x000a0;ml previously prepared DPPH solution (0.1&#x000a0;mM). Pure DPPH solution was used as control, and antioxidant activity was checked using formula<disp-formula id="e2"><mml:math id="M2"><mml:mrow><mml:mtext>DPHH&#x000a0;inhibition&#x000a0;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mtext>%</mml:mtext><mml:mo>)</mml:mo></mml:mrow><mml:mtext>&#x02002;</mml:mtext><mml:mo>=</mml:mo><mml:mtext>&#x02002;</mml:mtext><mml:mfrac><mml:mrow><mml:mtext>Abosrbance&#x000a0;of&#x000a0;control</mml:mtext><mml:mo>-</mml:mo><mml:mtext>absorbance&#x000a0;of&#x000a0;sample</mml:mtext></mml:mrow><mml:mrow><mml:mtext>absorbance&#x000a0;of&#x000a0;control</mml:mtext></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mtext>&#x000a0;</mml:mtext><mml:mn>100</mml:mn><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>
</p></sec></sec><sec id="s2-11"><title>Statistical Analysis</title><p>All experiments were performed in triplicate, and results were expressed as mean &#x000b1; SEM. In SWM tests, two-way repeated measures ANOVA followed by <italic>post hoc</italic> Bonferroni&#x02019;s tests were used. For Y-maze and brain tissue studies, one-way ANOVA followed by <italic>post hoc</italic> Tukey&#x02019;s test was employed. A value of <italic>p</italic> &#x0003c; 0.05 was considered as statistically significant. Whereas statistical analyses and figures were constructed <italic>via</italic> Graph Pad Prism-5 (Graph Pad Software Inc., San Diego, CA, United States).</p></sec></sec><sec sec-type="results|discussion" id="s3"><title>Results and Discussion</title><p>AD is a neurodegenerative disorder of the aging brain that is affecting large population, while its prevalence is expected to increase tremendously by 2050. The major issues associated with AD are the cognitive decline and behavioral turbulence which adversely affect the routine life of patients. Consequently, there is an immense need to develop more cost-effective drugs for the treatment of AD. In this scenario, natural products including medicinal plants provide an alternative platform for the development of novel therapeutic agents against AD. These phytotherapetic agents are cost-effective and biocompatible as compared to randomly synthesized compounds.</p><p>In our previous study, we reported in detail the phytochemistry and significance of identified compounds as potential AChE/BChE inhibitors (<xref rid="B9" ref-type="bibr">Ayaz et al., 2015</xref>). Among these, limonene is reported to provide neuroprotection against A&#x003b2;<sub>42</sub>-induced neurotoxicity in animal models of AD (<xref rid="B63" ref-type="bibr">Shin et al., 2020</xref>). Likewise, &#x003b2;-elemene enhances locomoter activity in animal models by reducing oxidative stress, neuronal apoptosis (<xref rid="B67" ref-type="bibr">Wang et al., 2018</xref>), and reduces inflammation in traumatic brain injury (<xref rid="B49" ref-type="bibr">Meng et al., 2018</xref>). &#x003b2;-caryophyllene offers numerous neuroprotective properties and reduces neuroinflammation (<xref rid="B30" ref-type="bibr">Francomano et al., 2019</xref>). Several other compounds like nerolidol (<xref rid="B40" ref-type="bibr">Javed et al., 2016</xref>), benzofuran (<xref rid="B21" ref-type="bibr">Cho et al., 2015</xref>), farnesene (<xref rid="B65" ref-type="bibr">Turkez et al., 2014</xref>), &#x003b2;-mycrene (<xref rid="B23" ref-type="bibr">Ciftci et al., 2014</xref>), juniper camphor (<xref rid="B13" ref-type="bibr">Bais et al., 2015</xref>), and androstan (<xref rid="B18" ref-type="bibr">Cai et al., 2017</xref>) have well established antioxidant, anti-neuroinflammatory, and neuroprotective potentials as reported in these studies. These components might contribute to the overall neuroprotective properties of Ph. Lo. Subsequently, the Ph. Lo being more active were evaluated in more detail using transgenic animal models.</p><sec id="s3-1"><title>Shallow Water Maze (SWM) Paradigm</title><p>Keeping in view the ethno-pharmacological profile and our preliminary studies, the Ph. Lo were studied in detail using the transgenic animal model of AD. SWM is a recently developed tool and adopted from Morris water maze (MWM) as some rodents feel trouble in swimming. Both tools are specialized and extensively employed in behavioral neuroscience for the cognitive assessment (<xref rid="B52" ref-type="bibr">Morris, 1981</xref>). In the SWM test, disease control animals treated with 10&#x000a0;mg/kg of Ph. Lo for 5&#x000a0;days showed significant improvement in cognitive performance indicated by low escape times <bold>(</bold>
<xref ref-type="fig" rid="F2">Figure 2</xref>). As observed on day 1, a gradual improvement was observed in transgenic animals with a steady decline in escape time as noticed from day 1 38.33 &#x000b1; 7.76&#x02013;15.33 &#x000b1; 4.39&#x000a0;s on 5th day of treatment, which was found to be comparable with the normal animals. Transgenic untreated animals showed high escape time (59.00 &#x000b1; 6.28&#x000a0;s day one) with no significant change (44.66 &#x000b1; 8.96&#x000a0;s on 5th day) during the training and test trials. In contrary, transgenic animals treated with standard drug galantamine exhibited gradual improvement in cognitive performance with gradual decline in escape times in comparison to test control and disease control animals. Essential oil from <italic>Zataria multiflora</italic> also improves learning and special memory in rats using Morris water maze task (<xref rid="B29" ref-type="bibr">Eskandari-Roozbahani et al., 2019</xref>). Cardamom oil supplementation for 42&#x000a0;days significantly reduced (<italic>p</italic> &#x0003c; 0.001 in comparison to diseases control group) escape latency in aluminum chloride&#x02013;administered animals, which signify their cognitive enhancing potentials (<xref rid="B6" ref-type="bibr">Auti and Kulkarni, 2019</xref>). Further, it also reduced aluminum chloride induced increase in transfer latency in elevated plus maze. Carvacrol, an essential component of volatile oils, rescued learning and memory dysfunctions in reperfusion-induced ischemic model using the Morris water maze model (<xref rid="B34" ref-type="bibr">Guan et al., 2019</xref>). Likewise, Antarctic Krill oil improved special learning and memory in SAMP8 mice using Morris water maze and Barnes maze indicated by decline escape latency (<xref rid="B44" ref-type="bibr">Li et al., 2018</xref>).</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Results of the SWM test performed on various groups of animals. Each value represents an average &#x000b1; SEM of three independent experiments. **, ##: <italic>p</italic> &#x0003c; 0.01; ***, ###: <italic>p</italic> s &#x0003c; 0.001. ns: values significantly different as compared to the normal group.</p></caption><graphic xlink:href="fphar-11-580069-g002"/></fig></sec><sec id="s3-2"><title>Y-maze Paradigm</title><p>Animals were also tested using another cognitive assessment tool Y-maze. Transgenic animals treated with 10&#x000a0;mg/kg of Ph. Lo showed considerable decline in escape time during the course of therapy and improved spontaneous alternation behavior (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). The average escape times observed were 12.75 &#x000b1; 3.04 (day 1st), 19.66 &#x000b1; 4.22 (day 2nd), 17.66 &#x000b1; 3.25 (day 3rd), 14.16 &#x000b1; 2.93 (day 4th), and 12.50 &#x000b1; 4.33&#x000a0;s on 5th day of Ph. Lo administration. Spontaneous alternation was much improved 37.33 &#x000b1; 4.17% in transgenic animals on 5th day of Ph. Lo therapy in comparison to disease control animals (26.33 &#x000b1; 2.38%) and standard control group animals (40.83 &#x000b1; 2.99), respectively. Previously, several essential oils and their components were reported to improve cognitive performance of animals indicated by improved spontaneous alternation activity. For instance, &#x003b1;-pinene, a volatile component, is reported to considerably improve special recognition memory in scopolamine-induced amnesia model using Y-maze (<xref rid="B43" ref-type="bibr">Lee et al., 2017</xref>). Oils from other sources like fish oil and peanut oils mixture are reported to improve spontaneous alternation behavior in the Y-maze test (<xref rid="B69" ref-type="bibr">Xiang et al., 2016</xref>).</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Y-maze test on various groups of animals. <bold>(A)</bold> Escape latency (sec). <bold>(B)</bold> Spontaneous alternation behavior (%). Each value represents an average &#x000b1; SEM of three independent experiments. **, ##: <italic>p</italic> &#x0003c; 0.01; ***, ###: <italic>p</italic> s &#x0003c; 0.001.</p></caption><graphic xlink:href="fphar-11-580069-g003"/></fig></sec><sec id="s3-3"><title>Open Field Study</title><p>Pharmacological effect of Ph. Lo on the exploratory behavior (locomotion) and anxiety was assessed <italic>via</italic> the open field test. Transgenic animals (untreated) showed less exploratory behavior indicated by number of line crossing (11.00 &#x000b1; 0.57) and spent 9.66 &#x000b1; 0.33 and 29.50 &#x000b1; 1.72&#x000a0;min in central and peripheral chambers of the compartment (<xref ref-type="fig" rid="F4">Figures 4A,B</xref>). The same animals given 10&#x000a0;mg/kg Ph. Lo exhibited improvement in exploratory behavior (46.00 &#x000b1; 5.19 lines crossed in 30&#x000a0;s) and spent 14.33 &#x000b1; 0.88 and 11.50 &#x000b1; 0.86 min in peripheral and central areas indicating less anxiety, when compared to the diazepam-treated group. The Ph. Lo therapy was comparatively more effective than our previously reported work on beta-sitosterol (<xref rid="B10" ref-type="bibr">Ayaz et al., 2017a</xref>), possibly <italic>via</italic> the liphophilic character of Ph. Lo to cross BBB (<xref rid="B1" ref-type="bibr">Agatonovic-Kustrin et al., 2020</xref>). Effect of <italic>Eplingiella fruticosa</italic> leaf essential oil on locomotor behavior of animals is previously reported (<xref rid="B15" ref-type="bibr">Beserra-Filho et al., 2019</xref>). Their results revealed a significant improvement in locomotor activity of the animals. Antarctic krill oil also improves special memory, exploratory, and locomoter activity of SAMP8 mice using open field as indicated by increased movements and reduced anxiety (<xref rid="B44" ref-type="bibr">Li et al., 2018</xref>). Cardamom oil administered for 42&#x000a0;days at 100 and 200&#x000a0;mg/kg orally has significantly improved (<italic>p</italic> &#x0003c; 0.001) locomotor behavior of rats in the aluminum chloride&#x02013;induced neurotoxicity model (<xref rid="B6" ref-type="bibr">Auti and Kulkarni, 2019</xref>).</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Effect of Ph. Lo in the open field test in various groups of animals. <bold>(A)</bold> Number of lines crossed by various group of animals. <bold>(B)</bold> Exploration times in minutes.</p></caption><graphic xlink:href="fphar-11-580069-g004"/></fig></sec><sec id="s3-4"><title>Balance Beam Study</title><p>In order to appraise the effect of Ph. Lo on the balance and coordination of transgenic animals, the balance beam test was used (<xref rid="B47" ref-type="bibr">Luong et al., 2011</xref>). This tool is widely used to analyze motor skills in rodents and response to drug therapy after brain injuries and diseases. Ph. Lo administration significantly augmented the motor and coordination abilities of transgenic animals when compared to other groups of animals <bold>(</bold>
<xref ref-type="fig" rid="F5">Figure 5</xref>). Tyrosol, a phenolic component of olive oil, exhibited neuroprotective potentials in the cerebral ischemic model. Tyrosol at dose of 10, 20, and 30&#x000a0;mg/kg significantly improved balance and coordination in animals as indicated by latency time (<xref rid="B17" ref-type="bibr">Bu et al., 2007</xref>). Likewise, &#x003b2;-caryophyllene, which is identified in Ph. Lo and so many other essential oils, is reported to improve motor coordination in the MPTP-induced Parkinson&#x02019;s diseases model using balance beam paradigm (<xref rid="B17" ref-type="bibr">Bu et al., 2007</xref>).</p><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>Effect of Ph. Lo on motor skills and coordination in animals groups.</p></caption><graphic xlink:href="fphar-11-580069-g005"/></fig></sec><sec id="s3-5"><title>Neurochemical Studies</title><sec id="s3-5-1"><title>Effect of Ph. Lo on Cortical and Hippocampus AChE</title><p>It is now well established that deterioration of cholinergeic neurons (ACh releasing neurons) whose cell bodies are present in the basal forebrain occur in AD patients. As these neuron innervate cortex and other areas, as a result of their gradual degeneration cognitive decline and memory impairment results (<xref rid="B25" ref-type="bibr">Coyle et al., 1983</xref>). Thus, the brain cholinergic system is targeted as potential treatment for AD patients (<xref rid="B32" ref-type="bibr">Giovannini et al., 1997</xref>). One strategy is the use of ACh degrading enzymes to maintain it for prolong time at the synapse and to improve its pharmacological activity (<xref rid="B54" ref-type="bibr">Oddo and LaFerla, 2006</xref>; <xref rid="B48" ref-type="bibr">Martorana et al., 2010</xref>). Keeping in view the significance of ACh in neurotransmission, cognition, and its deficiency in AD patients (<xref rid="B68" ref-type="bibr">Whitehouse et al., 1982</xref>), the AChE level was analyzed in the FC and HC areas of the brain. In the current study, we observed that the activity of ACh degrading enzymes was considerably declined which subsequently improved the cognitive performance of experimental animals. AChE activity was considerably low in FC (15.66 &#x000b1; 2.02%) and HC (8.66 &#x000b1; 2.02%) tissue homogenates in comparison to the standard group animals (<xref ref-type="fig" rid="F6">Figure 6</xref>).</p><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>AChE activity in the cortex and hippocampus tissues.</p></caption><graphic xlink:href="fphar-11-580069-g006"/></fig></sec><sec id="s3-5-2"><title>Effect of Ph. Lo on Cortical and Hippocampus BChE</title><p>ACh plays a significant role in cholinergic signaling in the brain which results in transmission of impulses across the synapse. BChE beside AChE hydrolyzes and recycles ACh after release in the synapse, especially when the AChE level is down. So both AChE and BChE are potential targets to inhibit ACh degradation and relieve symptomology of the AD patients. BChE levels are reported to increase in AD patients and their inhibition <italic>via</italic> the use of cholinesterase inhibitors can restore the level of ACh at synapse and enhance cognitive performance of AD patients (<xref rid="B53" ref-type="bibr">Nordberg et al., 2013</xref>; <xref rid="B39" ref-type="bibr">Jasiecki and Was&#x00105;g, 2019</xref>). In the current study, considerable BChE activity was observed in the FC (44.00 &#x000b1; 6.65%) and HC (24.66 &#x000b1; 1.33%) area of the brain in the disease group of animals (<xref ref-type="fig" rid="F7">Figure 7</xref>). The BChE activity was significantly reduced by the galantamine as recorded for the standard control group in the FC and HC regions of transgenic animals having percent BChE activity of 12.33 &#x000b1; 3.48 (<italic>p</italic> &#x0003c; 0.05) and 12.66 &#x000b1; 2.02 (<italic>p</italic> &#x0003c; 0.001), respectively. Moreover, the BChE activity was observed as 22.00 &#x000b1; 1.88% in FC of transgenic animals treated with Ph. Lo which was recorded to be significantly different (<italic>p</italic> &#x0003c; 0.01) as compared to the disease control group. The Ph. Lo treated group of transgenic animals showed BChE activity 14.00 &#x000b1; 2.82% with <italic>p</italic> &#x0003e; 0.05. Several clinical trials with aromatherapy are reported to improve cognitive performance, reduce agitation, aggression, and psychotic symptoms in AD and Parkinsonism patients (<xref rid="B41" ref-type="bibr">Jimbo et al., 2009</xref>; <xref rid="B2" ref-type="bibr">Ali et al., 2015</xref>; <xref rid="B62" ref-type="bibr">Scuteri et al., 2017</xref>). However, the exact underlying mechanisms of these beneficial effects are not fully discovered yet.</p><fig id="F7" position="float"><label>FIGURE 7</label><caption><p>BChE activity in the cortex and hippocampus tissues.</p></caption><graphic xlink:href="fphar-11-580069-g007"/></fig></sec><sec id="s3-5-3"><title>Effect of Ph. Lo on Cortical and Hippocampus Free Radicals</title><p>Results of the DPPH free radical scavenging assay (<italic>ex vivo</italic>) in the cortex have been summarized in <xref ref-type="fig" rid="F8">Figures 8</xref> and <xref ref-type="fig" rid="F9">9</xref>. The free radical scavenging potential recorded for the standard control group, that is, ascorbic acid was 43.33 &#x000b1; 4.66%. The antioxidant potential shown by the disease control group was recorded to be 15.33 &#x000b1; 2.02%. Whereas the Ph. Lo treated group exhibited antioxidant potential of 32.33 &#x000b1; 1.45% in the cortical tissues of transgenic animals. Moreover, the ascorbic acid&#x02013;treated group and transgenic animal groups treated with Ph. Lo demonstrated 57.66 &#x000b1; 6.43% and 52.33 &#x000b1; 6.43% antioxidant effects, respectively. Previous studies indicated that cardamom oil administration reduced free radical load in the cortex and hippocampus and improved antioxidant enzymes in the aluminum oxide&#x02013;induced neurotoxicity model (<xref rid="B6" ref-type="bibr">Auti and Kulkarni, 2019</xref>). The present study demostrated that Ph. Lo have significant <italic>in vitro</italic> cholinesterase inhibitory and free radical scavenging potentials. Moreover, AChE and BChE inhibitory activities in the FC and HC tissues of transgenic animals were also demostrated, which suggest its ability to inhibit these target enzymes in the brain regions. Hence, ACh level is maintained for prolong time in synaptic cleft which stimulates the cholinergic receptors. Ph. Lo essential oils&#x02013;mediated enhanced cholinergic transmission can be useful for memory restoration in AD and also preventing free radical&#x02013;induced neurodegeneration in the aging brain.</p><fig id="F8" position="float"><label>FIGURE 8</label><caption><p>Effect of Ph. Lo therapy on free radicals in FC.</p></caption><graphic xlink:href="fphar-11-580069-g008"/></fig><fig id="F9" position="float"><label>FIGURE 9</label><caption><p>Effect of Ph. Lo therapy on free radicals in HC.</p></caption><graphic xlink:href="fphar-11-580069-g009"/></fig></sec></sec></sec><sec sec-type="conclusion" id="s4"><title>Conclusion</title><p>Our previous anti-cholinesterase and antioxidant studies on Ph. Lo and Ph. Fo motivated us for further detailed studies in specific animal models. In this study, Ph. Lo exhibited significant improvement in cognitive performance of the animals in SWM, Y-maze, open field, and balance beam studies. Moreover, Frontal cortex and hippocampus studies of the treated transgenic animals revealed that Ph. Lo significantly inhibit cholinesterase's in the target sites and reduce free radical load. However, further studies regarding their exact mechanism of absorption into their target sites inside the brain are required. The combined antioxidant and cholinesterase inhibitory potentials of the oils indicate that it is effective on more than one target which advantageous as compared to currently available drugs. We suggest further studies regarding its effects on A&#x003b2;.</p></sec><sec sec-type="data-availability" id="s6"><title>Data Availability Statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec><sec id="s7"><title>Ethics Statement</title><p>The animal study was reviewed and approved by the Departmental Research Ethics Committee (DREC) with reference no. DREC/20160502/01.</p></sec><sec id="s8"><title>Author Contributions</title><p>MA, FU, AS, MS, MO, and AH performed experimental, data analysis, and drafting of original manuscript. XT, XL, and MK refined the manuscript, funded the project, and helped in revising the manuscript after review. All authors read and approved the final version of the manuscript.</p></sec><sec sec-type="COI-statement" id="s9"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>Authors cordially acknowledge funding sources to execute the project including National Natural Science Funds of China (Grant No. 81373714), National Natural Science Funds of China (Grant No. 81704170), Project of Heilongjiang Province Administration of traditional Chinese medicine (Grant No. ZHY16&#x02013;003), Heilongjiang postdoctoral initiation fund (Grant No. LBH-Q18117), the Special Fund of Harbin Science and Technology Innovation Talents Research (Grant No. 2016RAXYJ096), and Chunhui Plan of the Ministry of Education (Grant No. Z2009-1&#x02013;15030).</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Agatonovic-Kustrin</surname><given-names>S.</given-names></name><name><surname>Chan</surname><given-names>C. K. Y.</given-names></name><name><surname>Gegechkori</surname><given-names>V.</given-names></name><name><surname>Morton</surname><given-names>D. W.</given-names></name></person-group> (<year>2020</year>). <article-title>Models for skin and brain penetration of major components from essential oils used in aromatherapy for dementia patients</article-title>. <source>J. Biomol. Struct. Dyn</source>. <volume>38</volume> (<issue>8</issue>), <fpage>2402</fpage>&#x02013;<lpage>2411</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2019.1633408</pub-id>
<pub-id pub-id-type="pmid">31204906</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ali</surname><given-names>B.</given-names></name><name><surname>Al-Wabel</surname><given-names>N. A.</given-names></name><name><surname>Shams</surname><given-names>S.</given-names></name><name><surname>Ahamad</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>S. A.</given-names></name><name><surname>Anwar</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Essential oils used in aromatherapy: a systemic review</article-title>. <source>Asian Pac. J. Trop. Biomed</source>. <volume>5</volume> (<issue>8</issue>), <fpage>601</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1016/j.apjtb.2015.05.007</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Muhammad</surname><given-names>S.</given-names></name><name><surname>Shah</surname><given-names>M. R.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Rashid</surname><given-names>U.</given-names></name><name><surname>Farooq</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Neurologically potent molecules from <italic>Crataegus oxyacantha</italic>; isolation, anticholinesterase inhibition, and molecular docking</article-title>. <source>Front. Pharmacol</source>. <volume>8</volume>, <fpage>327</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2017.00327</pub-id>
<pub-id pub-id-type="pmid">28638340</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alzheimer&#x02019;s</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>2010 Alzheimer&#x02019;s disease facts and figures</article-title>. <source>Alzheimers Dement</source>. <volume>6</volume> (<issue>2</issue>), <fpage>158</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2010.01.009</pub-id>
<pub-id pub-id-type="pmid">20298981</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arendash</surname><given-names>G. W.</given-names></name><name><surname>Gordon</surname><given-names>M. N.</given-names></name><name><surname>Diamond</surname><given-names>D. M.</given-names></name><name><surname>Austin</surname><given-names>L. A.</given-names></name><name><surname>Hatcher</surname><given-names>J. M.</given-names></name><name><surname>Jantzen</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Behavioral assessment of Alzheimer&#x02019;s transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory</article-title>. <source>DNA Cell Biol</source>. <volume>20</volume> (<issue>11</issue>), <fpage>737</fpage>&#x02013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1089/10445490152717604</pub-id>
<pub-id pub-id-type="pmid">11788052</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Auti</surname><given-names>S. T.</given-names></name><name><surname>Kulkarni</surname><given-names>Y. A.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuroprotective effect of cardamom oil against aluminum induced neurotoxicity in rats</article-title>. <source>Front. Neurol</source>. <volume>10</volume>, <fpage>399</fpage>
<pub-id pub-id-type="doi">10.3389/fneur.2019.00399</pub-id>
<pub-id pub-id-type="pmid">31114535</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Ovais</surname><given-names>M.</given-names></name><name><surname>Khalil</surname><given-names>A. T.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>
<italic>Persicaria hydropiper</italic> (L.) delarbre: a review on traditional uses, bioactive chemical constituents and pharmacological and toxicological activities</article-title>. <source>J. Ethnopharmacol</source>. <volume>251</volume>, <fpage>112516</fpage>
<pub-id pub-id-type="doi">10.1016/j.jep.2019.112516</pub-id>
<pub-id pub-id-type="pmid">31884037</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Junaid</surname><given-names>M.</given-names></name><name><surname>Ahmed</surname><given-names>J.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from <italic>Polygonum hydropiper</italic> L</article-title>. <source>BMC Compl. Alternative Med</source>. <volume>14</volume> (<issue>1</issue>), <fpage>145</fpage>
<pub-id pub-id-type="doi">10.1186/1472-6882-14-145</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Junaid</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>M. A.</given-names></name><name><surname>Ahmad</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from <italic>Polygonum hydropiper</italic> L: a preliminary anti&#x02014;Alzheimer&#x02019;s study</article-title>. <source>Lipids Health Dis</source>. <volume>14</volume> (<issue>1</issue>), <fpage>141</fpage>
<pub-id pub-id-type="doi">10.1186/s12944-015-0145-8</pub-id>
<pub-id pub-id-type="pmid">26530857</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Junaid</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Subhan</surname><given-names>F.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Ali</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2017a</year>). <article-title>Anti-Alzheimer&#x02019;s studies on &#x003b2;-sitosterol isolated from <italic>Polygonum hydropiper</italic> L</article-title>. <source>Front. Pharmacol</source>. <volume>8</volume>, <fpage>697</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2017.00697</pub-id>
<pub-id pub-id-type="pmid">29056913</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Junaid</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Subhan</surname><given-names>F.</given-names></name><name><surname>Ahmed</surname><given-names>J.</given-names></name></person-group> (<year>2017b</year>). <article-title>Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants</article-title>. <source>Front. Aging Neurosci</source>. <volume>9</volume>, <fpage>168</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2017.00168</pub-id>
<pub-id pub-id-type="pmid">28611658</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Junaid</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Ovais</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders</article-title>. <source>Front. Aging Neurosci</source>. <volume>11</volume>
<bold><italic>,</italic></bold>
<fpage>155</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2019.00155</pub-id>
<pub-id pub-id-type="pmid">31293414</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bais</surname><given-names>S.</given-names></name><name><surname>Gill</surname><given-names>N.</given-names></name><name><surname>Kumar</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Neuroprotective effect of juniperus communis on chlorpromazine induced parkinson disease in animal model</article-title>. <source>Chin. J. Biol. <italic>2015</italic></source>. <pub-id pub-id-type="doi">10.1155/2015/542542</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baum</surname><given-names>L.</given-names></name><name><surname>Ng</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer&#x02019;s disease animal models</article-title>. <source>J. Alzheimers Dis</source>. <volume>6</volume> (<issue>4</issue>), <fpage>367</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.3233/jad-2004-6403</pub-id>
<pub-id pub-id-type="pmid">15345806</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Beserra-Filho</surname><given-names>J. I. A.</given-names></name><name><surname>de Mac&#x000ea;do</surname><given-names>A. M.</given-names></name><name><surname>Le&#x000e3;o</surname><given-names>A. H. F. F.</given-names></name><name><surname>Bispo</surname><given-names>J. M. M.</given-names></name><name><surname>Santos</surname><given-names>J. R.</given-names></name><name><surname>de Oliveira-Melo</surname><given-names>A. J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>
<italic>Eplingiella fruticosa</italic> leaf essential oil complexed with &#x003b2;-cyclodextrin produces a superior neuroprotective and behavioral profile in a mice model of Parkinson&#x02019;s disease</article-title>. <source>Food Chem. Toxicol</source>. <volume>124</volume>, <fpage>17</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2018.11.056</pub-id>
<pub-id pub-id-type="pmid">30481574</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bradford</surname><given-names>M. M.</given-names></name></person-group> (<year>1976</year>). <article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title>. <source>Anal. Biochem</source>. <volume>72</volume> (<issue>1&#x02013;2</issue>), <fpage>248</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1006/abio.1976.9999</pub-id>
<pub-id pub-id-type="pmid">942051</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bu</surname><given-names>Y.</given-names></name><name><surname>Rho</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>M. Y.</given-names></name><name><surname>Lee</surname><given-names>D. H.</given-names></name><name><surname>Kim</surname><given-names>S. Y.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Neuroprotective effect of tyrosol on transient focal cerebral ischemia in rats</article-title>. <source>Neurosci. Lett</source>. <volume>414</volume> (<issue>3</issue>), <fpage>218</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2006.08.094</pub-id>
<pub-id pub-id-type="pmid">17316989</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Chew</surname><given-names>C.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>F.</given-names></name><name><surname>Sengelaub</surname><given-names>D. R.</given-names></name></person-group> (<year>2017</year>). <article-title>Neuroprotective effects of testosterone metabolites and dependency on receptor action on the morphology of somatic motoneurons following the death of neighboring motoneurons</article-title>. <source>Dev. Neurobiol</source>. <volume>77</volume> (<issue>6</issue>), <fpage>691</fpage>&#x02013;<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22445</pub-id>
<pub-id pub-id-type="pmid">27569375</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chan</surname><given-names>Y. C.</given-names></name><name><surname>Wang</surname><given-names>M. F.</given-names></name><name><surname>Chen</surname><given-names>Y. C.</given-names></name><name><surname>Yang</surname><given-names>D. Y.</given-names></name><name><surname>Lee</surname><given-names>M. S.</given-names></name><name><surname>Cheng</surname><given-names>F. C.</given-names></name></person-group> (<year>2003</year>). <article-title>Long-term administration of <italic>Polygonum multiflorum</italic> Thunb. reduces cerebral ischemia-induced infarct volume in gerbils</article-title>. <source>Am. J. Chin. Med</source>. <volume>31</volume> (<issue>01</issue>), <fpage>71</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1142/S0192415X03000734</pub-id>
<pub-id pub-id-type="pmid">12723756</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>L. W.</given-names></name><name><surname>Wang</surname><given-names>Y. Q.</given-names></name><name><surname>Wei</surname><given-names>L. C.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Chan</surname><given-names>Y. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson&#x02019;s disease</article-title>. <source>CNS Neurol. Disord. Drug Targets</source>
<volume>6</volume> (<issue>4</issue>), <fpage>273</fpage>&#x02013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.2174/187152707781387288</pub-id>
<pub-id pub-id-type="pmid">17691984</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cho</surname><given-names>J.</given-names></name><name><surname>Park</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Bose</surname><given-names>S.</given-names></name><name><surname>Choi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Neuroprotective and antioxidant effects of novel benzofuran-2-carboxamide derivatives</article-title>. <source>Biomol. Ther</source>. <volume>23</volume> (<issue>3</issue>), <fpage>275</fpage>
<pub-id pub-id-type="doi">10.4062/biomolther.2015.030</pub-id>
</mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choleris</surname><given-names>E.</given-names></name><name><surname>Thomas</surname><given-names>A.</given-names></name><name><surname>Kavaliers</surname><given-names>M.</given-names></name><name><surname>Prato</surname><given-names>F.</given-names></name></person-group> (<year>2001</year>). <article-title>A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field</article-title>. <source>Neurosci. Biobehav. Rev</source>. <volume>25</volume>, <fpage>235</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/s0149-7634(01)00011-2</pub-id>
<pub-id pub-id-type="pmid">11378179</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ciftci</surname><given-names>O.</given-names></name><name><surname>Oztanir</surname><given-names>M. N.</given-names></name><name><surname>Cetin</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuroprotective effects of &#x003b2;-myrcene following global cerebral ischemia/reperfusion-mediated oxidative and neuronal damage in a C57BL/J6 mouse</article-title>. <source>Neurochem. Res</source>. <volume>39</volume> (<issue>9</issue>), <fpage>1717</fpage>&#x02013;<lpage>1723</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-014-1365-4</pub-id>
<pub-id pub-id-type="pmid">24972849</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Clark</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <source>Guide for the care and use of laboratory animals</source> (<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academy of Science</publisher-name>). </mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coyle</surname><given-names>J. T.</given-names></name><name><surname>Price</surname><given-names>D. L.</given-names></name><name><surname>Delong</surname><given-names>M. R.</given-names></name></person-group> (<year>1983</year>). <article-title>Alzheimer&#x02019;s disease: a disorder of cortical cholinergic innervation</article-title>. <source>Science</source>
<volume>219</volume> (<issue>4589</issue>), <fpage>1184</fpage>&#x02013;<lpage>1190</lpage>. <pub-id pub-id-type="doi">10.1126/science.6338589</pub-id>
<pub-id pub-id-type="pmid">6338589</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Shallow water (paddling) variants of water maze tests in mice</article-title>. <source>J. Vis. Exp</source>. (<issue>76</issue>), <fpage>e2608</fpage>
<pub-id pub-id-type="doi">10.3791/2608</pub-id>
</mixed-citation></ref><ref id="B27"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Eisdorfer</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <source>Psychopharmacology and aging</source>. <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer Science and Business Media</publisher-name>. </mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ellman</surname><given-names>G. L.</given-names></name><name><surname>Courtney</surname><given-names>K. D.</given-names></name><name><surname>Andres</surname><given-names>V.</given-names></name><name><surname>Feather-Stone</surname><given-names>R. M.</given-names></name></person-group> (<year>1961</year>). <article-title>A new and rapid colorimetric determination of acetylcholinesterase activity</article-title>. <source>Biochem. Pharmacol</source>. <volume>7</volume>, <fpage>88</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(61)90145-9</pub-id>
<pub-id pub-id-type="pmid">13726518</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eskandari-Roozbahani</surname><given-names>N.</given-names></name><name><surname>Shomali</surname><given-names>T.</given-names></name><name><surname>Taherianfard</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Neuroprotective effect of <italic>Zataria multiflora</italic> essential oil on rats with Alzheimer disease: a mechanistic study</article-title>. <source>Basic Clin. Neurosci</source>. <volume>10</volume> (<issue>1</issue>), <fpage>85</fpage>
<pub-id pub-id-type="doi">10.32598/bcn.9.10.270</pub-id>
<pub-id pub-id-type="pmid">31031896</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Francomano</surname><given-names>F.</given-names></name><name><surname>Caruso</surname><given-names>A.</given-names></name><name><surname>Barbarossa</surname><given-names>A.</given-names></name><name><surname>Fazio</surname><given-names>A.</given-names></name><name><surname>La Torre</surname><given-names>C.</given-names></name><name><surname>Ceramella</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>&#x003b2;-Caryophyllene: a sesquiterpene with countless biological properties</article-title>. <source>Appl. Sci</source>. <volume>9</volume> (<issue>24</issue>), <fpage>5420</fpage>
<pub-id pub-id-type="doi">10.3390/app9245420</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frautschy</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>P.</given-names></name><name><surname>Miller</surname><given-names>S.</given-names></name><name><surname>Chu</surname><given-names>T.</given-names></name><name><surname>Harris-White</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology</article-title>. <source>Neurobiol. Aging</source>
<volume>22</volume> (<issue>6</issue>), <fpage>993</fpage>&#x02013;<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-4580(01)00300-1</pub-id>
<pub-id pub-id-type="pmid">11755008</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Giovannini</surname><given-names>M.</given-names></name><name><surname>Casamenti</surname><given-names>F.</given-names></name><name><surname>Bartolini</surname><given-names>L.</given-names></name><name><surname>Pepeu</surname><given-names>G.</given-names></name></person-group> (<year>1997</year>). <article-title>The brain cholinergic system as a target of cognition enhancers</article-title>. <source>Behav. Brain Res</source>. <volume>83</volume> (<issue>1&#x02013;2</issue>), <fpage>1</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(97)86038-x</pub-id>
<pub-id pub-id-type="pmid">9062653</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Gould</surname><given-names>T. D.</given-names></name><name><surname>Dao</surname><given-names>D. T.</given-names></name><name><surname>Kovacsics</surname><given-names>C. E.</given-names></name></person-group> (<year>2009</year>). <source>Mood and anxiety related phenotypes in mice</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Humana Press</publisher-name>, <fpage>1</fpage>&#x02013;<lpage>20</lpage>. </mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>P.</given-names></name><name><surname>Ba</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>The neuroprotective effects of carvacrol on ischemia/reperfusion-induced hippocampal neuronal impairment by ferroptosis mitigation</article-title>. <source>Life Sci</source>. <volume>235</volume>, <fpage>116795</fpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2019.116795</pub-id>
<pub-id pub-id-type="pmid">31470002</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hiremathad</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>A review: natural compounds as anti-Alzheimer's disease agents</article-title>. <source>Curr. Nutr. Food Sci</source>. <volume>13</volume> (<issue>4</issue>), <fpage>247</fpage>&#x02013;<lpage>254</lpage>. </mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huq</surname><given-names>A.</given-names></name><name><surname>Jamal</surname><given-names>J. A.</given-names></name><name><surname>Stanslas</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Ethnobotanical, phytochemical, pharmacological, and toxicological aspects of <italic>Persicaria hydropiper</italic> (L.) Delarbre</article-title>. <source>Evid. Based Complement. Alternat. Med</source>. <volume>2014</volume>, <fpage>782830</fpage>
<pub-id pub-id-type="doi">10.1155/2014/782830</pub-id>
<pub-id pub-id-type="pmid">24834098</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Imran</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Shah</surname><given-names>M. R.</given-names></name><name><surname>Jan</surname><given-names>M. S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Anticholinesterase and antioxidant potentials of <italic>Nonea micrantha</italic> Bioss. &#x00026; Reut along with GC-MS analysis</article-title>. <source>BMC Compl. Alternative Med</source>. <volume>17</volume> (<issue>1</issue>), <fpage>499</fpage>
<pub-id pub-id-type="doi">10.1186/s12906-017-2004-9</pub-id>
</mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Isoma</surname><given-names>K.</given-names></name><name><surname>Ishikawa</surname><given-names>M.</given-names></name><name><surname>Ohta</surname><given-names>M.</given-names></name><name><surname>Ogawa</surname><given-names>Y.</given-names></name><name><surname>Hasegawa</surname><given-names>H.</given-names></name><name><surname>Kohda</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Effects of T-82, a new quinoline derivative, on cholinesterase activity and extracellular acetylcholine concentration in rat brain</article-title>. <source>Jpn. J. Pharmacol</source>. <volume>88</volume> (<issue>2</issue>), <fpage>206</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1254/jjp.88.206</pub-id>
<pub-id pub-id-type="pmid">11928722</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jasiecki</surname><given-names>J.</given-names></name><name><surname>Was&#x00105;g</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Butyrylcholinesterase protein ends in the pathogenesis of alzheimer&#x02019;s disease&#x02014;could BCHE genotyping Be helpful in Alzheimer&#x02019;s therapy?</article-title>
<source>Biomolecules</source>
<volume>9</volume> (<issue>10</issue>), <fpage>592</fpage>
<pub-id pub-id-type="doi">10.3390/biom9100592</pub-id>
</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Javed</surname><given-names>H.</given-names></name><name><surname>Azimullah</surname><given-names>S.</given-names></name><name><surname>Abul Khair</surname><given-names>S. B.</given-names></name><name><surname>Ojha</surname><given-names>S.</given-names></name><name><surname>Haque</surname><given-names>M. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone</article-title>. <source>BMC Neurosci</source>. <volume>17</volume> (<issue>1</issue>), <fpage>58</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1186/s12868-016-0293-4</pub-id>
<pub-id pub-id-type="pmid">27549180</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jimbo</surname><given-names>D.</given-names></name><name><surname>Kimura</surname><given-names>Y.</given-names></name><name><surname>Taniguchi</surname><given-names>M.</given-names></name><name><surname>Inoue</surname><given-names>M.</given-names></name><name><surname>Urakami</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Effect of aromatherapy on patients with Alzheimer&#x02019;s disease</article-title>. <source>Psychogeriatrics</source>
<volume>9</volume> (<issue>4</issue>), <fpage>173</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1111/j.1479-8301.2009.00299.x</pub-id>
<pub-id pub-id-type="pmid">20377818</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koehn</surname><given-names>F. E.</given-names></name><name><surname>Carter</surname><given-names>G. T.</given-names></name></person-group> (<year>2005</year>). <article-title>The evolving role of natural products in drug discovery</article-title>. <source>Nat. Rev. Drug Discov</source>. <volume>4</volume> (<issue>3</issue>), <fpage>206</fpage>
<pub-id pub-id-type="doi">10.1038/nrd1657</pub-id>
<pub-id pub-id-type="pmid">15729362</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>G.-Y.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Park</surname><given-names>G. H.</given-names></name><name><surname>Jang</surname><given-names>J.-H.</given-names></name></person-group> (<year>2017</year>). <article-title>Amelioration of scopolamine-induced learning and memory impairment by &#x003b1;-pinene in C57BL/6 mice</article-title>. <source>Evid. Base Compl. Alternative Med</source>. <volume>2017</volume>, <fpage>4926815</fpage>
<pub-id pub-id-type="doi">10.1155/2017/4926815</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Wen</surname><given-names>M.</given-names></name><name><surname>Yanagita</surname><given-names>T.</given-names></name><name><surname>Xue</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>The protective effect of antarctic krill oil on cognitive function by inhibiting oxidative stress in the brain of senescence-accelerated prone mouse strain 8 (SAMP8) mice</article-title>. <source>J. Food Sci</source>. <volume>83</volume> (<issue>2</issue>), <fpage>543</fpage>&#x02013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1111/1750-3841.14044</pub-id>
<pub-id pub-id-type="pmid">29350764</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name><name><surname>Murakami</surname><given-names>Y.</given-names></name><name><surname>Tezuka</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Kadota</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Neuroprotective effects of <italic>Polygonum multiflorum</italic> on nigrostriatal dopaminergic degeneration induced by paraquat and maneb in mice</article-title>. <source>Pharmacol. Biochem. Behav</source>. <volume>82</volume> (<issue>2</issue>), <fpage>345</fpage>&#x02013;<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2005.09.004</pub-id>
<pub-id pub-id-type="pmid">16214209</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>G. P.</given-names></name><name><surname>Chu</surname><given-names>T.</given-names></name><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Beech</surname><given-names>W.</given-names></name><name><surname>Frautschy</surname><given-names>S. A.</given-names></name><name><surname>Cole</surname><given-names>G. M.</given-names></name></person-group> (<year>2001</year>). <article-title>The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse</article-title>. <source>J. Neurosci</source>. <volume>21</volume> (<issue>21</issue>), <fpage>8370</fpage>&#x02013;<lpage>8377</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-21-08370.2001</pub-id>
<pub-id pub-id-type="pmid">11606625</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luong</surname><given-names>T. N.</given-names></name><name><surname>Carlisle</surname><given-names>H. J.</given-names></name><name><surname>Southwell</surname><given-names>A.</given-names></name><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Assessment of motor balance and coordination in mice using the balance beam</article-title>. <source>J. Vis. Exp</source>. <volume>10</volume> (<issue>49</issue>), <fpage>e2376</fpage>
<pub-id pub-id-type="doi">10.3791/2376</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martorana</surname><given-names>A.</given-names></name><name><surname>Esposito</surname><given-names>Z.</given-names></name><name><surname>Koch</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Beyond the cholinergic hypothesis: do current drugs work in Alzheimer&#x02019;s disease?</article-title>
<source>CNS Neurosci. Ther</source>. <volume>16</volume> (<issue>4</issue>), <fpage>235</fpage>&#x02013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1111/j.1755-5949.2010.00175.x</pub-id>
<pub-id pub-id-type="pmid">20560995</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Fan</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Beneficial effect of &#x003b2;-elemene alone and in combination with hyperbaric oxygen in traumatic brain injury by inflammatory pathway</article-title>. <source>Transl. Neurosci</source>. <volume>9</volume> (<issue>1</issue>), <fpage>33</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1515/tnsci-2018-0007</pub-id>
<pub-id pub-id-type="pmid">29992051</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mihaylova</surname><given-names>D.</given-names></name><name><surname>Vrancheva</surname><given-names>R.</given-names></name><name><surname>Ivanov</surname><given-names>I.</given-names></name><name><surname>Popova</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Phytochemical profile and antioxidant activity of water pepper (<italic>Polygonum hydropiper</italic> L.)</article-title>. <source>J. Microbiol. Biotechnol. Food Sci</source>. <volume>8</volume> (<issue>5</issue>), <fpage>1205</fpage>&#x02013;<lpage>1208</lpage>. </mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mir</surname><given-names>N. T.</given-names></name><name><surname>Saleem</surname><given-names>U.</given-names></name><name><surname>Anwar</surname><given-names>F.</given-names></name><name><surname>Ahmad</surname><given-names>B.</given-names></name><name><surname>Ullah</surname><given-names>I.</given-names></name><name><surname>Hira</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Lawsonia Inermis markedly improves cognitive functions in animal models and modulate oxidative stress markers in the brain</article-title>. <source>Medicina</source>
<volume>55</volume> (<issue>5</issue>), <fpage>192</fpage>
<pub-id pub-id-type="doi">10.3390/medicina55050192</pub-id>
</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morris</surname><given-names>R. G. M.</given-names></name></person-group> (<year>1981</year>). <article-title>Spatial localization does not require the presence of local cues</article-title>. <source>Learn. Motiv</source>. <volume>12</volume> (<issue>2</issue>), <fpage>239</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/0023-9690(81)90020-5</pub-id>
</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nordberg</surname><given-names>A.</given-names></name><name><surname>Ballard</surname><given-names>C.</given-names></name><name><surname>Bullock</surname><given-names>R.</given-names></name><name><surname>Darreh-Shori</surname><given-names>T.</given-names></name><name><surname>Somogyi</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer&#x02019;s disease</article-title>. <source>Prim. Care Companion CNS Disord</source>. <volume>15</volume> (<issue>2</issue>), <fpage>12r01412</fpage>
<pub-id pub-id-type="doi">10.4088/PCC.12r01412</pub-id>
</mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oddo</surname><given-names>S.</given-names></name><name><surname>LaFerla</surname><given-names>F. M.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of nicotinic acetylcholine receptors in Alzheimer&#x02019;s disease</article-title>. <source>J. Physiol. Paris</source>
<volume>99</volume> (<issue>2&#x02013;3</issue>), <fpage>172</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphysparis.2005.12.080</pub-id>
<pub-id pub-id-type="pmid">16448808</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Hasegawa</surname><given-names>K.</given-names></name><name><surname>Naiki</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils <italic>in vitro</italic>
</article-title>. <source>J. Neurosci. Res</source>. <volume>75</volume> (<issue>6</issue>), <fpage>742</fpage>&#x02013;<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.20025</pub-id>
<pub-id pub-id-type="pmid">14994335</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ovais</surname><given-names>M.</given-names></name><name><surname>Zia</surname><given-names>N.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name><name><surname>Khalil</surname><given-names>A. T.</given-names></name><name><surname>Raza</surname><given-names>A.</given-names></name><name><surname>Ayaz</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Phyto-therapeutic and nanomedicinal approaches to cure Alzheimer's disease: present status and future opportunities</article-title>. <source>Front. Aging Neurosci</source>. <volume>10</volume>, <fpage>284</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2018.00284</pub-id>
<pub-id pub-id-type="pmid">30405389</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Pocivavsek</surname><given-names>A.</given-names></name><name><surname>Notarangelo</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Bruno</surname><given-names>J.</given-names></name><name><surname>Schwarcz</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <source>Modeling the psychopathological dimensions of schizophrenia</source>. <publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Elsevier</publisher-name>. </mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rates</surname><given-names>S. M. K.</given-names></name></person-group> (<year>2001</year>). <article-title>Plants as source of drugs</article-title>. <source>Toxicon</source>
<volume>39</volume> (<issue>5</issue>), <fpage>603</fpage>&#x02013;<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1016/s0041-0101(00)00154-9</pub-id>
<pub-id pub-id-type="pmid">11072038</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rice-Evans</surname><given-names>C. A.</given-names></name><name><surname>Miller</surname><given-names>N. J.</given-names></name><name><surname>Paganga</surname><given-names>G.</given-names></name></person-group> (<year>1996</year>). <article-title>Structure-antioxidant activity relationships of flavonoids and phenolic acids</article-title>. <source>Free Radic. Biol. Med</source>. <volume>20</volume> (<issue>7</issue>), <fpage>933</fpage>&#x02013;<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1016/0891-5849(95)02227-9</pub-id>
<pub-id pub-id-type="pmid">8743980</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Mahmood</surname><given-names>F.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Haq</surname><given-names>F. U.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Synthesis, anticholinesterase and antioxidant potentials of ketoesters derivatives of succinimides: a possible role in the management of Alzheimer&#x02019;s</article-title>. <source>Chem. Cent. J</source>. <volume>9</volume> (<issue>1</issue>), <fpage>31</fpage>
<pub-id pub-id-type="doi">10.1186/s13065-015-0107-2</pub-id>
<pub-id pub-id-type="pmid">26064188</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Zeb</surname><given-names>A.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Rashid</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Chemical characterization, analgesic, antioxidant, and anticholinesterase potentials of essential oils from isodon rugosus wall. ex. Benth</article-title>. <source>Front. Pharmacol</source>. <volume>9</volume>, <fpage>623</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2018.00623</pub-id>
<pub-id pub-id-type="pmid">29950997</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scuteri</surname><given-names>D.</given-names></name><name><surname>Morrone</surname><given-names>L. A.</given-names></name><name><surname>Rombol&#x000e0;</surname><given-names>L.</given-names></name><name><surname>Avato</surname><given-names>P. R.</given-names></name><name><surname>Bilia</surname><given-names>A. R.</given-names></name><name><surname>Corasaniti</surname><given-names>M. T.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Aromatherapy and aromatic plants for the treatment of behavioural and psychological symptoms of dementia in patients with Alzheimer&#x02019;s disease: clinical evidence and possible mechanisms</article-title>. <source>Evid. Based Compl. Alternat. Med</source>. <volume>2017</volume>, <fpage>9416305</fpage>
<pub-id pub-id-type="doi">10.1155/2017/9416305</pub-id>
</mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shin</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>Q. F.</given-names></name><name><surname>Choi</surname><given-names>B.</given-names></name><name><surname>Shin</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>B.</given-names></name><name><surname>Yuan</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Neuroprotective effects of limonene (+) against a&#x003b2;42-induced neurotoxicity in a drosophila model of Alzheimer&#x02019;s disease</article-title>. <source>Biol. Pharm. Bull</source>. <volume>43</volume> (<issue>3</issue>), <fpage>409</fpage>&#x02013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b19-00495</pub-id>
<pub-id pub-id-type="pmid">31875578</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trevisan</surname><given-names>M. T. S.</given-names></name><name><surname>Macedo</surname><given-names>F. b. V. V.</given-names></name><name><surname>Meent</surname><given-names>M. v. d.</given-names></name><name><surname>Rhee</surname><given-names>I. K.</given-names></name><name><surname>Verpoorte</surname><given-names>R.</given-names></name></person-group> (<year>2003</year>). <article-title>Screening for acetylcholinesterase inhibitors from plants to treat Alzheimer's disease</article-title>. <source>Qu&#x000c3;mica Nova</source>
<volume>26</volume> (<issue>3</issue>), <fpage>301</fpage>&#x02013;<lpage>304</lpage>. </mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turkez</surname><given-names>H.</given-names></name><name><surname>Sozio</surname><given-names>P.</given-names></name><name><surname>Geyikoglu</surname><given-names>F.</given-names></name><name><surname>Tatar</surname><given-names>A.</given-names></name><name><surname>Hacimuftuoglu</surname><given-names>A.</given-names></name><name><surname>Di Stefano</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity <italic>in vitro</italic>
</article-title>. <source>Cell. Mol. Neurobiol</source>. <volume>34</volume> (<issue>1</issue>), <fpage>101</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-013-9991-y</pub-id>
<pub-id pub-id-type="pmid">24105026</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Hussain</surname><given-names>A.</given-names></name><name><surname>Ahmad</surname><given-names>S.</given-names></name><name><surname>Imran</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Phenolic, flavonoid contents, anticholinesterase and antioxidant evaluation of <italic>Iris germanica</italic> var; florentina</article-title>. <source>Nat. Prod. Res</source>. <volume>30</volume> (<issue>12</issue>), <fpage>1440</fpage>&#x02013;<lpage>1444</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2015.1057585</pub-id>
<pub-id pub-id-type="pmid">26166432</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Ren</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Local delivery of &#x003b2;-elemene improves locomotor functional recovery by alleviating endoplasmic reticulum stress and reducing neuronal apoptosis in rats with spinal cord injury</article-title>. <source>Cell. Physiol. Biochem</source>. <volume>49</volume> (<issue>2</issue>), <fpage>595</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1159/000492996</pub-id>
<pub-id pub-id-type="pmid">30165357</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whitehouse</surname><given-names>P. J.</given-names></name><name><surname>Price</surname><given-names>D. L.</given-names></name><name><surname>Struble</surname><given-names>R. G.</given-names></name><name><surname>Clark</surname><given-names>A. W.</given-names></name><name><surname>Coyle</surname><given-names>J. T.</given-names></name><name><surname>Delon</surname><given-names>M. R.</given-names></name></person-group> (<year>1982</year>). <article-title>Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain</article-title>. <source>Science</source>
<volume>215</volume> (<issue>4537</issue>), <fpage>1237</fpage>&#x02013;<lpage>1239</lpage>. <pub-id pub-id-type="doi">10.1126/science.7058341</pub-id>
<pub-id pub-id-type="pmid">7058341</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiang</surname><given-names>L.</given-names></name><name><surname>Cao</surname><given-names>X. L.</given-names></name><name><surname>Xing</surname><given-names>T. Y.</given-names></name><name><surname>Mori</surname><given-names>D.</given-names></name><name><surname>Tang</surname><given-names>R. Q.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Mixture of peanut skin extract and fish oil improves memory in mice <italic>via</italic> modulation of anti-oxidative stress and regulation of BDNF/ERK/CREB signaling pathways</article-title>. <source>Nutrients</source>
<volume>8</volume> (<issue>5</issue>), <fpage>256</fpage>
<pub-id pub-id-type="doi">10.3390/nu8050256</pub-id>
</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>F.</given-names></name><name><surname>Lim</surname><given-names>G. P.</given-names></name><name><surname>Begum</surname><given-names>A. N.</given-names></name><name><surname>Ubeda</surname><given-names>O. J.</given-names></name><name><surname>Simmons</surname><given-names>M. R.</given-names></name><name><surname>Ambegaokar</surname><given-names>S. S.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid <italic>in vivo</italic>
</article-title>. <source>J. Biol. Chem</source>. <volume>280</volume> (<issue>7</issue>), <fpage>5892</fpage>&#x02013;<lpage>5901</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M404751200</pub-id>
<pub-id pub-id-type="pmid">15590663</pub-id></mixed-citation></ref></ref-list></back></article>